Surface-engineered GFET biosensors improve antifouling and molecular sieving, indicating better performance in biofluids.
Graphene field-effect transistors (GFETs) promise label-free biosensing but suffer from nonspecific protein adsorption and poor selectivity in complex biofluids. Herein, we proposed a surface-engineering strategy to endow GFET arrays with antifouling robustness and molecular-sieving selectivity. Two fluorine-rich covalent organic framework (F-COF) films synthesized at the liquid-liquid interface were transferred onto GFET channels through a gentle, solvent-free lamination protocol, creating F-COF/GFET sensors with high transconductance and typical bipolar characteristics of graphene. F-COF films in the modified GFET sensors functioned as size-selective gates for smaller metal ions (e.g., divalent cations like Zn2+), but excluded anionic methyl orange and larger cationic Rhodamine B. The F-COF/GFET sensors reduced the nonspecific protein adsorption and allowed the detection of Ca2+ at low concentrations (10-6 M) when exposed to a simulated physiological milieu containing 10-4 M bovine serum albumin. Decoupling antifouling from recognition at the monomer level provides a generalizable strategy for selective, real-time GFET biosensors in biofluids.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: